Cefpodoxime-d3

Cefpodoxime-d3 is the stable isotope-labeled counterpart of cefpodoxime, used in biomedical research and drug development. Cefpodoxime is a third-generation cephalosporin antibiotic that exerts antibacterial activity by inhibiting bacterial cell wall synthesis. Its primary targets are bacterial penicillin-binding proteins (PBPs), thereby disrupting the cross-linking process of the bacterial cell wall, leading to bacterial lysis and death. As an isotope-labeled compound, cefpodoxime-d3 is used in pharmacokinetic studies to trace the metabolic pathways and distribution of the drug in vivo, helping to better understand the absorption, distribution, metabolism, and excretion of cefpodoxime. In in vitro experiments, cefpodoxime shows nanomolar to micromolar minimum inhibitory concentrations (MICs) against a variety of Gram-positive and Gram-negative bacteria, with specific activity levels depending on the bacterial species and experimental conditions. In cellular and animal models, cefpodoxime-d3 can be used to study the drug’s bioavailability, metabolic stability, and excretion routes; the doses or concentrations used in experiments typically depend on the experimental design and research objectives. In addition, cefpodoxime-d3 can serve as an internal standard to improve sensitivity and accuracy in mass spectrometry analysis.